Emerging role of epidermal growth factor receptor inhibition in therapy for advanced malignancy: Focus on NSCLCLANGER, Corey J.International journal of radiation oncology, biology, physics. 2004, Vol 58, Num 3, pp 991-1002, issn 0360-3016, 12 p.Conference Paper

Lung tumor segmentation in PET images using graph cutsBALLANGAN, Cherry; XIUYING WANG; FULHAM, Michael et al.Computer methods and programs in biomedicine (Print). 2013, Vol 109, Num 3, pp 260-268, issn 0169-2607, 9 p.Article

Activity-based proteomics: Identification of ABHD11 and ESD activities as potential biomarkers for human lung adenocarcinomaWIEDL, T; ARNI, S; ROSCHITZKI, B et al.Journal of proteomics (Print). 2011, Vol 74, Num 10, pp 1884-1894, issn 1874-3919, 11 p.Article

Gefitinib ('Iressa'): a new therapy for advanced non-small-cell lung cancerRECK, Martin; GATZEMEIER, Ulrich.Respiratory medicine. 2005, Vol 99, Num 3, pp 298-307, issn 0954-6111, 10 p.Article

Molecular prognostic factors in resectable non-small cell lung cancerVIELH, P; SPANO, J.-P; GRENIER, J et al.Critical reviews in oncology/hematology. 2005, Vol 53, Num 3, pp 193-197, issn 1040-8428, 5 p.Article

Current approaches in chemotherapy of advanced and metastatic non-small cell lung cancer (NSCLC)RECK, Martin.Anticancer research. 2005, Vol 25, Num 3A, pp 1501-1506, issn 0250-7005, 6 p.Article

Comments on treatment strategy for locally advanced non-small cell lung cancerZWITTER, Matjaz.Lung cancer. 2002, Vol 38, pp S33-S35, issn 0169-5002, SUP3Article

Detection of epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) using a fully automated system with a nano-scale engineered biomagnetiteMARUYAMA, Kohei; TAKEYAMA, Haruko; MORI, Tetsushi et al.Biosensors & bioelectronics. 2007, Vol 22, Num 9-10, pp 2282-2288, issn 0956-5663, 7 p.Conference Paper

MAGE Expressions Mediated by Demethylation of MAGE Promoters Induce Progression of Non-small Cell Lung CancerYANAGAWA, Naoki; TAMURA, Gen; OIZUMI, Hiroyuki et al.Anticancer research. 2011, Vol 31, Num 1, pp 171-175, issn 0250-7005, 5 p.Article

Correlation between interleukin 6 production and tumor proliferation in non-small cell lung cancerYAMAJI, Haruko; IIZASA, Toshihiko; NAKAYAMA, Toshinori et al.Cancer immunology and immunotherapy. 2004, Vol 53, Num 9, pp 786-792, issn 0340-7004, 7 p.Article

Rationale of a relaunch of gefitinib in Caucasian non-small cell lung cancer patientsPIRCHER, Andreas; PLONER, Ferdinand; POPPER, Helmut et al.Lung cancer. 2010, Vol 69, Num 3, pp 265-271, issn 0169-5002, 7 p.Article

Compensation of type I and type II cytokeratin pools in lung cancerKANAJI, Nobuhiro; BANDOH, Shuji; FUJITA, Jiro et al.Lung cancer. 2007, Vol 55, Num 3, pp 295-302, issn 0169-5002, 8 p.Article

Glutathione S-transferase PI (GST-PI) mRNA expression and DNA methylation is involved in the pathogenesis and prognosis of NSCLCGRIMMINGER, Peter P; MAUS, Martin K. H; SCHNEIDER, Paul M et al.Lung cancer. 2012, Vol 78, Num 1, pp 87-91, issn 0169-5002, 5 p.Article

Immune activation status of CD8+ T cells infiltrating non-small cell lung cancerTROJAN, Andreas; UROSEVIC, Mirjana; DUMMER, Reinhard et al.Lung cancer. 2004, Vol 44, Num 2, pp 143-147, issn 0169-5002, 5 p.Article

Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cellsTAO, Hiroyuki; MIMURA, Yusuke; AOE, Keisuke et al.Lung cancer. 2012, Vol 75, Num 1, pp 95-101, issn 0169-5002, 7 p.Article

The identification of KRAS mutations at codon 12 in plasma DNA is not a prognostic factor in advanced non-small cell lung cancer patientsCAMPS, Carlos; JANTUS-LEWINTRE, Eloisa; SIRERA, Rafael et al.Lung cancer. 2011, Vol 72, Num 3, pp 365-369, issn 0169-5002, 5 p.Article

Expression of Bcl-2 predicts outcome in locally advanced non-small cell lung cancer patients treated with cisplatin-based concurrent chemoradiotherapySEONG HYUN JEONG; JAE HO JUNG; YOUNG TAEK OH et al.Lung cancer. 2010, Vol 68, Num 2, pp 288-294, issn 0169-5002, 7 p.Article

Phosphodiesterase inhibitors as anti-cancer drugsHIRSH, Liron; DANTES, Ada; SUH, Byong-Sun et al.Biochemical pharmacology. 2004, Vol 68, Num 6, pp 981-988, issn 0006-2952, 8 p.Article

Insufficiency of peripheral blood as a substitute tissue for detecting EGFR mutations in lung cancer: a meta-analysisZHIJUN LI; YONGJUN ZHANG; WENLONG BAO et al.Targeted oncology. 2014, Vol 9, Num 4, pp 381-388, issn 1776-2596, 8 p.Article

Pharmacogenetic study of patients with advanced non-small cell lung cancer (NSCLC) treated with second-line pemetrexed or pemetrexed―carboplatinTISEO, Marcello; GIOVANNETTI, Elisa; ARDIZZONI, Andrea et al.Lung cancer. 2012, Vol 78, Num 1, pp 92-99, issn 0169-5002, 8 p.Article

Carboplatin-based chemotherapy in patients with advanced non-small cell lung cancer and a poor performance statusSTINCHCOMBE, Thomas E; CHOI, Jaeun; SCHELL, Michael J et al.Lung cancer. 2006, Vol 51, Num 2, pp 237-243, issn 0169-5002, 7 p.Article

Complete spontaneous remission of non-small-cell lung cancer: a case reportCAFFERATA, M. A; CHIARAMONDIA, M; MONETTI, F et al.Lung cancer. 2004, Vol 45, Num 2, pp 263-266, issn 0169-5002, 4 p.Article

The prognostic significance of vascular endothelial growth factor levels in sera of non-small cell lung cancer patientsKAYA, Akin; CILEDAG, Aydin; GULBAY, Banu Eris et al.Respiratory medicine. 2004, Vol 98, Num 7, pp 632-636, issn 0954-6111, 5 p.Article

Resected non-small-cell lung cancer stage I/II: Indication for adjuvant/neoadjuvant therapy?HOFFMANN, Hans.Lung cancer. 2004, Vol 45, pp S91-S97, issn 0169-5002, SUP2Conference Paper

A phase II study of S-1 monotherapy as second-line treatment for advanced non-small cell lung cancerTOTANI, Yoshitaka; SAITO, Yuji; UCHIYAMA, Yasuhiro et al.Cancer chemotherapy and pharmacology. 2009, Vol 64, Num 6, pp 1181-1185, issn 0344-5704, 5 p.Article